• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个人态度对公共政策的影响。以神经管缺陷的产前筛查为例。

The effect of private attitudes on public policy. Prenatal screening for neural tube defects as a prototype.

作者信息

Pauker S G, Pauker S P, McNeil B J

出版信息

Med Decis Making. 1981;1(2):103-14. doi: 10.1177/0272989X8100100202.

DOI:10.1177/0272989X8100100202
PMID:6188939
Abstract

The quantitative use of patients' attitudes in medicine has thus far been limited to decisions involving either treatment alternatives or the use or nonuse of a particular diagnostic test. Preference theory has not been applied either to the use of screening tests or to the development of large-scale health-related public policy decisions. In this paper we have, in a prototypical fashion, analyzed the effect patient attitudes have on a public policy decision faced by many countries today--whether or not to institute a screening program for neural tube defects. We have assessed the attitudes of 338 prospective parents toward many of the sequelae expected from the introduction, or lack thereof, of the alpha-fetoprotein screening program--induced abortion from amniocentesis, elective abortion, and the birth of a defective child. Using these data and information collected by the United Kingdom study on alpha-fetoprotein, we have estimated the proportion of patients coming to genetic counseling who would benefit from the availability of a screening program for neural tube defects.

摘要

到目前为止,在医学中对患者态度的定量运用仅限于涉及治疗方案选择或特定诊断测试使用与否的决策。偏好理论尚未应用于筛查测试的使用或大规模健康相关公共政策决策的制定。在本文中,我们以一种典型的方式分析了患者态度对当今许多国家面临的一项公共政策决策的影响——是否实施神经管缺陷筛查项目。我们评估了338位准父母对甲胎蛋白筛查项目实施或未实施所预期的许多后遗症的态度,这些后遗症包括羊膜穿刺术导致的人工流产、选择性流产以及有缺陷孩子的出生。利用这些数据以及英国关于甲胎蛋白的研究所收集的信息,我们估计了前来接受遗传咨询的患者中,将从神经管缺陷筛查项目中受益的比例。

相似文献

1
The effect of private attitudes on public policy. Prenatal screening for neural tube defects as a prototype.个人态度对公共政策的影响。以神经管缺陷的产前筛查为例。
Med Decis Making. 1981;1(2):103-14. doi: 10.1177/0272989X8100100202.
2
Maternal serum alpha fetoprotein testing: some public policy considerations.
Women Health. 1981 Spring-Summer;6(1-2):147-53.
3
Early pregnancy screening for neural tube defects in Israel.以色列对神经管缺陷的早期妊娠筛查。
Isr J Med Sci. 1986 Mar-Apr;22(3-4):210-4.
4
Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.针对有神经管缺陷家族史的妊娠,无常规羊膜腔穿刺术的产前诊断策略。
Am J Med Genet. 1987 Jan;26(1):103-10. doi: 10.1002/ajmg.1320260117.
5
Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.孕妇血清甲胎蛋白筛查用于神经管缺陷的检测。
West J Med. 1983 Apr;138(4):524-30.
6
Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.超声检查正常但孕妇血清甲胎蛋白升高:羊膜穿刺术是否总是必要?对26069例筛查患者的回顾
Obstet Gynecol. 1988 Feb;71(2):203-7.
7
Prenatal testing for maternal serum alpha-fetoprotein.
Am Fam Physician. 1987 Apr;35(4):169-74.
8
The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
UCLA Forum Med Sci. 1978;20:199-205.
9
[Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
Zentralbl Gynakol. 1988;110(3):158-67.
10
Prevalence of neural tube defects in United States Army treatment facilities, 1975-1985; cost analysis of routine screening.1975 - 1985年美国陆军治疗机构中神经管缺陷的患病率;常规筛查的成本分析
Mil Med. 1988 Jun;153(6):293-5.

引用本文的文献

1
Improving health care by understanding patient preferences: the role of computer technology.通过了解患者偏好改善医疗保健:计算机技术的作用。
J Am Med Inform Assoc. 1998 May-Jun;5(3):257-62. doi: 10.1136/jamia.1998.0050257.
2
Talking with patients about risk.
J Gen Intern Med. 1988 Mar-Apr;3(2):166-70. doi: 10.1007/BF02596126.